News
One in six Americans suffers from recurrent headaches. Congress can help.
That was the message from hundreds of patient advocates who gathered at the U.S. Capitol for this year’s Headache on the Hill. People living with migraine and other headache disorders use the annual event to highlight legislative solutions that could improve their health care – and their lives.
Headache experts have aligned on the best way to prevent migraine attacks. In newly updated guidance, the American Headache Society’s new position statement highlights CGRP inhibitors as the first-line approach to migraine prevention. First approved by the FDA in 2018, the medications can also reduce pain if they’re administered during a migraine attack.
A “how-to” toolkit on advocating for access to migraine treatment by removing insurance barriers.
For many women, her annual well-woman appointment may be the one time a year she speaks with a doctor about her health. And given that women suffer from migraines at a rate three times that of men, amending the Well-Women screening to include questions about the disease has the potential to benefit many women.
